在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

  1. 首頁
  2. 試劑盒
  3. 酶聯免疫試劑盒
  4. Human Beta-Ala-His dipeptidase(CNDP1) ELISA kit

Human Beta-Ala-His dipeptidase(CNDP1) ELISA kit

  • 中文名稱：
    人肌肽二肽酶(CNDP1)酶聯免疫試劑盒
  • 貨號：
    CSB-EL005639HU
  • 規格：
    96T/48T
  • 價格：
    ￥3600/￥2500
  • 其他：

產品詳情

  • 產品描述：
    人肌肽二肽酶(CNDP1)酶聯免疫試劑盒（CSB-EL005639HU）為雙抗夾心法ELISA試劑盒，定量檢測血清、血漿、組織勻漿樣本中的CNDP1含量。試劑盒檢測范圍為0.156 ng/mL-10 ng/mL，適用于細胞生物學、代謝疾病模型或神經退行性疾病機制等科研場景中CNDP1蛋白表達的動態分析，尤其適合檢測生物樣本中低豐度目標分子，為探索CNDP1在疾病發生發展中的功能提供可靠工具。本品僅用于科研，不用于臨床診斷，產品具體參數及操作步驟詳見產品說明書。
  • 別名：
    Beta Ala His dipeptidase ELISA Kit; Beta-Ala-His dipeptidase ELISA Kit; Carnosinase 1 ELISA Kit; Carnosinase1 ELISA Kit; Carnosine dipeptidase 1 (metallopeptidase M20 family) ELISA Kit; Carnosine dipeptidase 1 ELISA Kit; CN1 ELISA Kit; CNDP 1 ELISA Kit; CNDP dipeptidase 1 ELISA Kit; Cndp1 ELISA Kit; CNDP1_HUMAN ELISA Kit; CPGL2 ELISA Kit; Glutamate carboxypeptidase like protein 2 ELISA Kit; Glutamate carboxypeptidase-like protein 2 ELISA Kit; HsT2308 ELISA Kit; MGC102737 ELISA Kit; MGC10825 ELISA Kit; MGC142072 ELISA Kit; OTTHUMP00000163751 ELISA Kit; Serum carnosinase ELISA Kit; UNQ1915/PRO4380 ELISA Kit
  • 縮寫：
    CNDP1
  • Uniprot No.：
  • 種屬：
    Homo sapiens (Human)
  • 樣本類型：
    serum, plasma, tissue homogenates
  • 檢測范圍：
    0.156 ng/mL-10 ng/mL
  • 靈敏度：
    0.04 ng/mL
  • 反應時間：
    1-5h
  • 樣本體積：
    50-100ul
  • 檢測波長：
    450 nm
  • 研究領域：
    Cancer
  • 測定原理：
    quantitative
  • 測定方法：
    Sandwich
  • 精密度：
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 線性度：
    To assess the linearity of the assay, samples were spiked with high concentrations of human CNDP1 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
    　 Sample Serum(n=4)
    1:1 Average % 92
    Range % 86-96
    1:2 Average % 101
    Range % 97-105
    1:4 Average % 91
    Range % 85-97
    1:8 Average % 94
    Range % 90-98
  • 回收率：
    The recovery of human CNDP1 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample Type Average % Recovery Range
    Serum (n=5) 102 95-108
    EDTA plasma (n=4) 94 87-98
  • 標準曲線：
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    ng/ml OD1 OD2 Average Corrected
    10 2.057 2.154 2.106 2.003
    5 1.460 1.576 1.518 1.415
    2.5 0.985 1.017 1.001 0.898
    1.25 0.663 0.673 0.668 0.565
    0.625 0.412 0.424 0.418 0.315
    0.312 0.269 0.274 0.272 0.169
    0.156 0.201 0.208 0.205 0.102
    0 0.102 0.103 0.103 　
  • 數據處理：
  • 貨期：
    3-5 working days

產品評價

靶點詳情

  • 功能：
    Catalyzes the peptide bond hydrolysis in Xaa-His dipeptides, displaying the highest activity toward carnosine (beta-alanyl-L-histidine) and anserine (beta-alanyl-3-methyl-histidine).
  • 基因功能參考文獻：
    1. The distribution of the (CTG)5 homozygous genotype in the no-diabetic nephropathy (DN) and clinical-DN patients was comparable, a lower frequency was found in the biopsy proven-DN patients, particularly in females. We observed a significant trend towards high frequencies of the (CTG)5 homozygous genotype with increased time on dialysis. PMID: 28553654
    2. Considering that approximately 40 per cent of the population are homozygous for the 5L allele of (CTG) n repeat polymorphism in CNDP1 gene and seem to be less prone to develop DN, it is needed to evaluate whether the majority of diabetic patients (who do not have the 5L-5L genotype) would be benefited from supplementation with carnosine or with a more intensive monitoring PMID: 27834319
    3. Compared to healthy individuals and those with diabetes but no kidney disease, patients with diabetic nephropathy exhibited lower frequencies of 5L-5L genotype and 5L allele of CNDP1 gene, suggesting that this allele might confer protection against development of kidney disease in this population. PMID: 27834323
    4. genetic association studies in pediatric population in Germany: Data suggest that, in pediatric patients with chronic kidney disease, the nephroprotective effect of CNDP1 Mannheim genetic variant against disease progression is not restricted to patients with diabetic nephropathy. PMID: 27278783
    5. The experimentally measured higher affinity of homocarnosine for the enzyme relative to l-carnosine might be explained, at least in part, by more extensive interactions inside the monomeric and dimeric hCN1's active site. PMID: 27105448
    6. Data shows that higher carnosine content in human skeletal muscle is positively associated with insulin resistance and fasting metabolic preference for glucose. PMID: 26439389
    7. In gastrointestinal cancer, reduced plasma levels of CNDP1 associate with signs of catabolism and poor outcome. PMID: 25898255
    8. Alterations of serum carnosinase (CN1) activity has been associated with several pathological conditions, such as neurological disorders, chronic diseases and cancer PMID: 24566305
    9. This meta-analysis confirms that the carnosinase D18S880 microsatellite polymorphism is associated with daibetic nephropathy susceptibility, especially in the type 2 DM and the Caucasian population. PMID: 23402577
    10. Rs12604675-A in CNDP1 may confer susceptibility to overt proteinuria in Japanese women with type 2 diabetes. PMID: 23342076
    11. In this review, correlations between serum carnosine and carnosinase activity and polymorphism in CNDP1 gene are analyzed. The role of CNDP1 gene polymorphism the development of diabetic nephropathy and non-diabetic chronic kidney disease is discussed. PMID: 22706107
    12. Plasma levels of FLT and S100A9 proteins are up-regulated and CNDP1 levels are down-regulated in patients with glioblastoma. PMID: 23029420
    13. These findings provide nominal evidence supporting a role between CNDP1 variants and diabetic kidney disease. PMID: 21393041
    14. neither CNDP1 genotype nor the normal variation in circulating testosterone levels affects the muscular carnosine content PMID: 20865290
    15. Serum histidine dipeptide concentrations are not correlated to serum carnosinase activity PMID: 20971102
    16. CNDP1 polymorphism predicts progression to ESRD in patients with diabetic nephropathies, but only late after baseline measurements. PMID: 20711718
    17. CTG polymorphism of the CNDP1 gene does not affect survival of Chinese peritoneal dialysis subjects. PMID: 20979941
    18. Hyperglycemia enhances CNDP1 secretion and enzyme activity; data suggest that poor blood glucose control in diabetic patients might result in an increased enzyme secretion even in the presence of the (CTG)(5) allele. PMID: 20460427
    19. Association between the CNDP1 gene and diabetic nephropathy is sex specific and independent of susceptibility for type 2 diabetes. PMID: 20332346
    20. GCP II mRNA was detected in glial cells. Glial-rich regions, specifically the DLPFC and ERC white matter and the molecular and polymorphic layers in the hippocampus, express high levels of GCP II mRNA. PMID: 14560319
    21. diabetic patients with the carnosinase CNDP1 gene Mannheim variant are less susceptible for nephropathy PMID: 16046297
    22. no difference in allele or genotype frequency between centenarians & controls or between cardiovascular patients & controls; the recently identified functional carnosinase variant does not contribute to longevity or protect against coronary heart disease PMID: 16965804
    23. CPGL-B may be associated with cell growth and metastasis of HCC. PMID: 17121880
    24. This replicates the CNDP1 gene association with diabetic nephropathy (DN) that was initially detected in European Caucasians and in Arabs, and further demonstrates that the CNDP1 gene and carnosine pathway appear to play a role in susceptibility to DN. PMID: 17205963
    25. Diabetic patients homozygous for CNDP1 are protected against diabetic nephropathy. PMID: 17601991
    26. CN1-dependent susceptibility to diabetic nephropathy may at least in part be mediated by altered glucose metabolism in type 2 diabetic patients. PMID: 17601992
    27. South Asian Surinamese have a lower frequency of the 5/5 homozygous genotype, which was associated with lower carnosinase activity and genetic risk for developing diabetic nephropathy. PMID: 19577318

    顯示更多

    收起更多

  • 亞細胞定位：
    Secreted.
  • 蛋白家族：
    Peptidase M20A family
  • 組織特異性：
    Found in serum and adult nervous central system. Absent in serum from patients with homocarnosinosis.
  • 數據庫鏈接：

    HGNC: 20675

    OMIM: 609064

    KEGG: hsa:84735

    STRING: 9606.ENSP00000351682

    UniGene: Hs.400613



主站蜘蛛池模板： 国产精品理论片在线观看| 国产成人亚洲综合无码精品 | 中文字幕无码免费久久| 亚洲免费网站观看视频| 色偷偷噜噜噜亚洲男人 | 男生白内裤自慰gv白袜男同| 国产成人无码a区在线| 日本爽爽爽爽爽爽在线观看免| 亚洲精品偷拍无码不卡av| 无码人妻精品一区二区三| 久久久久人妻一区精品性色av| 欧美兽交xxxx×视频| 久久丫精品国产| 亚洲欧洲国产成人综合在线观看 | 高清性欧美暴力猛交| 国产精品久久久久久| 和黑人邻居中文字幕在线| 色多多成视频人在线观看| 高大丰满熟妇丰满的大白屁股| 无码人妻精品一二三区免费| 日韩高清在线亚洲专区小说| 亚洲精品国产品国语在线观看| 夜夜躁日日躁狠狠久久av| 中国少妇大p毛茸茸| 色一情一乱一伦一区二区三区| 97久久超碰亚洲视觉盛宴| 色综合久久久无码中文字幕波多| 日日噜噜夜夜狠狠va视频| 麻豆国产丝袜白领秘书在线观看| 男人女人午夜视频免费| 无码一区二区三区| 久在线观看福利视频| av一区二区国产在线视频| 久久综合色_综合色88| 午夜成人爽爽爽视频在线观看| а天堂中文官网| 国产乡下三级全黄三级| 亚洲精品国产精品乱码不卡√| 137日本免费肉体摄影| av网站免费线看精品| 精品久久久久久成人av|